In a double-blind, placebo-controlled, dose-titration study, 1 to 3 g/day of oral propionyl-L-carnitine for 24 weeks was well tolerated and improved maximal walking distance in patients with intermittent claudication (64)
Buse has received fees for consultation and travel support for contracted activities that have been paid to the University of North Carolina by Adocia, AstraZeneca, Dance Biopharm, Dexcom, Eli Lilly, Fractyl, GI Dynamics, Intarcia Therapeutics, Lexicon, MannKind, Metavention, NovaTarg, Novo Nordisk, Orexigen, PhaseBio, Sanofi, Senseonics, vTv Therapeutics, and Zafgen
Details on an updated GAT Essentials Series have come in this week, which not only confirm a new look for the line but a few new supplements for it as well
There is a lot of promise shown in anti-aging as well as cancer therapies, and the studies that are being done should show whether or not it is a viable solution for many kinds of illnesses and problems that would otherwise be hard to treat